| A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer M Altinbas, HS Coskun, O Er, M Ozkan, B Eser, A Unal, M Cetin, S Soyuer Journal of thrombosis and haemostasis 2 (8), 1266-1271, 2004 | 606 | 2004 |
| Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study MG Kaya, M Ozkan, O Gunebakmaz, H Akkaya, EG Kaya, M Akpek, ... International journal of cardiology 167 (5), 2306-2310, 2013 | 358 | 2013 |
| Drug-induced lung disease M Ozkan, RA Dweik, M Ahmad Cleveland clinic journal of medicine 68 (9), 782-795, 2001 | 96 | 2001 |
| Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study A Alacacioglu, I Somali, I Simsek, I Astarcioglu, M Ozkan, C Camci, ... Japanese journal of clinical oncology 38 (10), 683-688, 2008 | 95 | 2008 |
| Risk factors of nasopharyngeal carcinoma in Turkey-an epidemiological survey of the Anatolian Society of Medical Oncology FP Turkoz, G Celenkoglu, GG Doğu, ME Kalender, U Coskun, N Alkis, ... Asian Pacific Journal of Cancer Prevention, 2011 | 74 | 2011 |
| Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer M Inanc, M Ozkan, H Karaca, V Berk, O Bozkurt, AO Duran, E Ozaslan, ... Medical oncology 31, 1-8, 2014 | 71 | 2014 |
| Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients AO Duran, M Inanc, H Karaca, I Dogan, V Berk, O Bozkurt, E Ozaslan, ... Asian Pacific Journal of Cancer Prevention 15 (15), 6449-6453, 2014 | 68 | 2014 |
| Prognostic factors and clinical outcome of patients with Ewing’s sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology E Arpaci, T Yetisyigit, M Seker, D Uncu, U Uyeturk, B Oksuzoglu, ... Medical Oncology 30, 1-7, 2013 | 62 | 2013 |
| Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma? B Cetin, V Berk, MA Kaplan, B Afsar, G Tufan, M Ozkan, A Isikdogan, ... Clinical genitourinary cancer 11 (2), 141-148, 2013 | 52 | 2013 |
| The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients N Kokturk, C Babayigit, S Kul, PD Cetinkaya, SA Nayci, SA Baris, ... Respiratory Medicine 183, 106433, 2021 | 50 | 2021 |
| Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin GG Dogu, M Ozkan, F Ozturk, M Dikilitas, O Er, A Ozturk Medical oncology 27, 34-39, 2010 | 50 | 2010 |
| The value of fiberoptic bronchoscopy in diagnosis of smear negative pulmonary tuberculosis I Yüksekol, S Bal, M Ozkan, A Balkan, I Bedirhan, E Tozkoparan, ... Tuberkuloz ve toraks 51 (4), 405-409, 2003 | 42 | 2003 |
| 24 DOF EMG controlled hybrid actuated prosthetic hand A Atasoy, E Kaya, E Toptas, S Kuchimov, E Kaplanoglu, M Ozkan 2016 38th Annual International Conference of the IEEE Engineering in …, 2016 | 41 | 2016 |
| Factors affecting prognosis in metastatic colorectal cancer patients B Eker, E Ozaslan, H Karaca, V Berk, O Bozkurt, M Inanc, AO Duran, ... Asian Pacific Journal of Cancer Prevention 16 (7), 3015-3021, 2015 | 41 | 2015 |
| Factors related to complementary/alternative medicine use among cancer patients in central Anatolia O Er, S Mistik, M Ozkan, A Ozturk, M Altinbas Tumori Journal 94 (6), 833-837, 2008 | 41 | 2008 |
| Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients O Bozkurt, H Karaca, V Berk, M Inanc, AO Duran, E Ozaslan, M Ucar, ... JBUON 12, 14, 2015 | 40 | 2015 |
| Irinotecan as a second-line monotherapy for small cell lung cancer A Sevinc, ME Kalender, M Altinbas, M Ozkan, M Dikilitas, C Camci, ... Asian Pac J Cancer Prev 12 (4), 1055-1059, 2011 | 39 | 2011 |
| Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology V Berk, MA Kaplan, O Tonyali, S Buyukberber, O Balakan, M Ozkan, ... Asian Pacific Journal of Cancer Prevention 14 (12), 7367-7369, 2013 | 38 | 2013 |
| Prognostic factors for overall survival in patients with metastatic colorectal carcinoma treated with vascular endothelial growth factor-targeting agents B Cetin, M Kaplan, V Berk, S Ozturk, M Benekli, A Isikdogan, M ÖZKAN, ... Asian Pacific Journal of Cancer Prevention 13 (3), 2012 | 37 | 2012 |
| Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experience M ÖZKAN, V Berk, M Kaplan, M Benekli, U Coskun, A Bilici, M Gumus, ... Neoplasma 59 (1), 2012 | 36 | 2012 |
